课题基金 / 基金详情

STUDY OF THE MECHANISM OF PEPSINOGEN SECRETION.

STUDY OF THE MECHANISM OF PEPSINOGEN SECRETION.
胃蛋白酶原分泌机制的研究。
批准号:
62480196
负责人:
INOUE Masaki
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1989

项目摘要

项目成果

INOUE Masaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To investigate the mechanism of pepsinogen secretion (PS), the three lines of studies have been done, and the following results were obtained.(1) The effects of agonists and intracellular messengers on the PS was observed in isolated frog pepsinogen acini. Adrenergic, cholinergic and bombesin stimulation caused dose-related increase in PS, and the latter two of them caused the increase in [Ca^<2+>]i simultaneously. DBcAMP, TPA and A23187 caused dose-related increase in pepsinogen secretion, any combination of the secretagogues caused additive or potentiative interaction in PG. The results suggest that the mechanism of PS involves three messenger pathways; cAMP, [Ca^<2+>]i and protein kinase C, and that [Ca^<2+>]i play a important role in the development of desensitization.(2) K^+ channels and cellar electrical potential were observed in the isolated frog oxyntic cells. The most frequent observed channels had a unit conductance 30-35 pS which was activated by DBcAMP and histamine. The higher conductance 55-60 PS channel was activated by cholinergic stimulation and Ca^<2+> ionophore. These channels were both highly selective for K^+. The magnitude of currents was reduced by Mg^<2+>. The two K^+ channels were inhibited by omeprazole. These results indicate that the K^+ channels are regulated by the secretagogues and intracellar messengers, and may be responsible for maintenance of membrane potential.(3) Omeprazole increased PS in both experimental and clinical observation. The effect of omeprazole may be not involve in the function of membrane receptors.
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
井上正規: "ペプシノ-ゲン分泌に関する実験的研究ーbiologically active peptideの影響についてー" 第30回ペプシン研究会記念シンポジウム「ペプシン・抗ペプシン剤の臨床」. 123-136 (1988)
Masanori Inoue:“胃蛋白酶原分泌的实验研究-生物活性肽的影响”第30届胃蛋白酶研究组纪念研讨会“胃蛋白酶和抗胃蛋白酶制剂的临床应用”123-136(1988)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
白川敏夫,井上正規,梶山梧朗他: "Omeprazoleの酸、並びにペプシノ-ゲン分泌に及ぼす影響に関する検討" 胃分泌研究会誌. 20. 117-120 (1988)
Toshio Shirakawa、Masanori Inoue、Goro Kajiyama 等人:“奥美拉唑对胃酸和胃蛋白酶原分泌的影响的研究”胃分泌研究学会杂志 20. 117-120 (1988)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Shirakawa;B.I.Hirschowitz: Am.J.Physiol.250. 484-488 (1986)
T.Shirakawa;B.I.Hirschowitz:Am.J.Physiol.250。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Shirakawa;B.I.Hirschowitz: Am.J.Physiol.250. 668-673 (1986)
T.Shirakawa;B.I.Hirschowitz:Am.J.Physiol.250。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Development of oncolytic virotherapy against the refractory gynecologic cancers
    • 批准号:
      21390450
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2009
    • 负责人:
      INOUE Masaki
    • 依托单位:
    Targeting the molecules useful for the diagnosis and treatment of endometrial cancers
    • 批准号:
      17390448
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.72万
    • 财政年份:
      2005
    • 负责人:
      INOUE Masaki
    • 依托单位:
    Detection of the hypennethylation of MLH1 promoter and its clinical application in endometrial cancer screening
    • 批准号:
      13557137
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.1万
    • 财政年份:
      2001
    • 负责人:
      INOUE Masaki
    • 依托单位:
    Gene therapy against ovarian cancers using hTERT promoter
    • 批准号:
      12470339
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2000
    • 负责人:
      INOUE Masaki
    • 依托单位:
    海外基金